All In Biotech

Free tool

FAERS Monitor: Men'S Rogaine

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021812 or its brand name (Men'S Rogaine, Minoxidil). Reports on generic versions are filed under their own applications.

Reports

44,887

Serious

4,801

11% of reports

Hospitalization

2,105

Death reported

454

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • adverse drug reaction8,621
  • drug ineffective7,781
  • alopecia3,745
  • application site pruritus2,976
  • off label use2,224
  • application site irritation1,441
  • application site pain1,432
  • overdose1,413
  • hair texture abnormal1,402
  • headache1,355
  • incorrect dose administered1,331
  • inappropriate schedule of product administration1,196
  • wrong technique in product usage process1,183
  • product use in unapproved indication1,150
  • pruritus1,002

Reports by year received

View as table
YearReports
200495
2005122
2006128
200789
2008113
2009130
2010149
2011167
2012219
2013152
2014196
20152,015
20162,755
20172,715
20182,301
20192,081
20203,225
20215,591
20228,463
20236,201
20243,687
20252,671
20261,622

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,009,272 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
application site pruritusSignal2,97670.668.0177,519
application site irritationSignal1,44161.258.075,496
hair texture abnormalSignal1,40254.751.866,214
adverse drug reactionSignal8,62149.648.6373,016
application site painSignal1,43232.530.840,904
alopeciaSignal3,7459.18.826,691
inappropriate schedule of product administrationSignal1,1963.13.01,728
overdoseSignal1,4133.12.91,994
drug ineffectiveSignal7,7812.82.79,381
wrong technique in product usage processSignal1,1832.72.61,316
incorrect dose administeredSignal1,3312.72.61,479
product use in unapproved indicationSignal1,1502.22.1738
pruritus1,0021.21.141
off label use2,2241.21.170
headache1,3551.01.00

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.